InvestmentJul 8, 2026, 06:07 AM
Aethlon Medical Raises $4.0M in Follow-On Offering
AI Summary
Aethlon Medical, Inc. announced the pricing and closing of a follow-on public offering, raising gross proceeds of $4.0 million. The offering included common stock, common warrants, pre-funded warrants, and placement agent warrants, priced at $0.71 per unit. The net proceeds of approximately $3.335 million will be used for general corporate purposes, including research and development, clinical trials, and working capital.
Key Highlights
- Aethlon Medical raised gross proceeds of $4.0 million from the offering.
- Net proceeds to the company were approximately $3.335 million after fees and expenses.
- The offering included 263,000 shares of common stock and warrants to purchase 11,226,018 shares.
- The combined public offering price was $0.71 per share (or pre-funded warrant) and accompanying warrant.
- Maxim Group LLC acted as placement agent, receiving a 6.25% cash fee ($260,000) and 225,320 placement agent warrants.
- The company and its officers/directors are subject to a 90-day lock-up period on certain equity issuances.
Price Impact
More from AEMD